This is a working overview of size exclusion chromatography, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-03-05. Anything still debated is marked as such rather than presented as settled.
Storage and handling of collagen peptides require protection from moisture, heat, and light. The powders are hygroscopic and can absorb water from the air, leading to clumping or microbial growth. Typical storage conditions are a cool, dry place at room temperature or below, in tightly sealed containers. Some manufacturers recommend refrigeration for long-term stability. Solutions prepared from the powder are less stable and should be used promptly or preserved according to validated protocols.
Production of collagen peptides begins with raw materials such as bovine hide, porcine skin, fish scales, or poultry cartilage. The collagen is extracted, often with acid or alkaline treatment, and then subjected to hydrolysis using enzymes like pepsin or alcalase, or chemical agents. Enzymatic hydrolysis is favored for its mild conditions and controllability. The resulting mixture is filtered, concentrated, and dried to yield a powder. Process parameters such as temperature, pH, and enzyme-to-substrate ratio determine the molecular weight profile and yield.
Analytical methods for collagen peptides focus on molecular weight distribution, amino acid composition, and purity. Size exclusion chromatography with UV detection is widely used to estimate molecular weight ranges. High-performance liquid chromatography can quantify hydroxyproline after acid hydrolysis. Mass spectrometry provides detailed sequence information for individual peptides. Other tests include moisture content, ash, heavy metals, and microbial limits. The choice of method depends on the specific quality attribute and the required sensitivity.
Collagen peptides are distinguished from gelatin by their lower average molecular weight and better solubility in cold water. Gelatin forms gels upon cooling, while collagen peptides typically do not. Molecular weight distributions for commercial collagen peptides often range from about 2 to 20 kilodaltons, though exact profiles vary by manufacturer and process. Products may be sold as powders, capsules, or liquids. The term "collagen hydrolysate" is frequently used as a synonym, although labeling conventions differ across regions.
Collagen is a structural protein found in connective tissues of animals, and collagen peptides are short amino acid chains produced by hydrolyzing native collagen into smaller fragments. The hydrolysis process typically uses enzymes or acids under controlled conditions. Commercial collagen peptides often come from bovine hide, porcine skin, or fish scales. The resulting material is water-soluble and differs from intact collagen in molecular size and behavior. The term 'collagen peptide' generally refers to a mixture of peptide chains rather than a single defined molecule.
Production begins with cleaning and mincing raw collagen-rich tissues. The material undergoes pretreatment to remove non-collagenous components, followed by hydrolysis using enzymes such as pepsin or alcalase, or by acid or alkaline treatment. Reaction time, temperature, and pH influence the average molecular weight of the resulting peptides. After hydrolysis, the mixture is filtered, concentrated, and dried, often by spray drying. The final product is a powder with a characteristic amino acid profile rich in glycine, proline, and hydroxyproline.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | 15–25 °C | Protect from moisture and direct light. |
| Hygroscopicity | Absorbs moisture from air | Store in sealed containers to prevent clumping. |
| Common analytical method | Size exclusion chromatography | Estimates molecular weight distribution. |
| Solubility in water | Freely soluble | Forms clear solutions at typical concentrations. |
| Common synonyms | Collagen hydrolysate, hydrolyzed collagen | Terms often used interchangeably. |
One challenge in collagen peptide analysis is the absence of a single reference standard that covers all possible molecular weight fractions. Products from different sources or hydrolysis conditions yield different peptide profiles, complicating direct comparisons. Some laboratories use gelatin or a defined peptide mixture as a calibration standard, but this approach has limitations. Additionally, the term "collagen peptide" itself lacks a universally accepted molecular weight cutoff. Ongoing discussions aim to establish more consistent definitions and testing protocols for regulatory and research purposes.
Quality control of collagen peptides relies on methods that characterize molecular weight distribution, amino acid composition, and purity. Size exclusion chromatography (SEC) is commonly used to estimate the molecular weight profile of peptide mixtures. High-performance liquid chromatography (HPLC) can separate and quantify individual peptide fractions. Mass spectrometry provides detailed information on peptide sequences and modifications. These techniques help verify that a product meets declared specifications, though standardization across laboratories remains limited.
Additional tests assess moisture, ash, and nitrogen content to confirm overall composition and processing consistency. Heavy metal analysis, including lead, arsenic, cadmium, and mercury, is performed to ensure limits are not exceeded. Microbial testing checks for total aerobic counts, yeast, mold, and specific pathogens such as Salmonella and Escherichia coli. These safety parameters are often required by regulations for food or dietary supplement ingredients. Results are compared against internal or pharmacopeial specifications, which may differ between jurisdictions.
Common sources for collagen peptide production include bovine hide, porcine skin, fish skin, and poultry cartilage. The raw material is first cleaned and then treated with enzymes such as pepsin or microbial proteases under controlled conditions. Hydrolysis time, temperature, and enzyme concentration influence the final peptide size distribution. After hydrolysis, the mixture undergoes filtration, purification, and drying to yield a powder. The amino acid composition is notable for high levels of glycine, proline, and hydroxyproline, which are characteristic of collagen.
The functional properties of collagen peptides depend on their molecular weight profile and amino acid sequence. They are highly soluble in water and produce low-viscosity solutions even at relatively high concentrations. Some peptides exhibit surface activity, which allows them to act as emulsifiers or foaming agents in food systems. The absence of a rigid triple-helical structure distinguishes them from gelatin, which can form gels upon cooling. Chromatographic separation and mass analysis are used to characterize the peptide mixture.
Collagen peptides are short chains of amino acids derived from collagen, a structural protein found in connective tissues such as skin, bone, and cartilage. The production process involves breaking native collagen into smaller fragments through hydrolysis, which cleaves peptide bonds. Unlike intact collagen, these peptides dissolve in water and do not form a triple helix. Commercial preparations typically contain peptides with molecular weights ranging from about 2,000 to 20,000 daltons. The term collagen peptide is often used interchangeably with hydrolyzed collagen or collagen hydrolysate.
Quality control for collagen peptides includes measurements of moisture content, ash, protein content, and heavy metals. Microbial limits are set to ensure food or cosmetic grade safety, and the degree of hydrolysis serves as a key process indicator. That indicator correlates with molecular weight distribution and solubility characteristics. Regulatory requirements vary by country, and some jurisdictions restrict label claims about health effects. Documentation such as certificates of analysis and safety data sheets typically accompanies commercial shipments of the material.
Analytical testing of collagen peptides focuses on identity, purity, and molecular weight profile. Size-exclusion chromatography separates peptides by hydrodynamic volume and is often calibrated with known protein standards. Amino acid analysis after acid hydrolysis provides the compositional profile, which can confirm the collagen origin. Mass spectrometry offers detailed sequence information for individual peptides. These methods together help ensure that a product matches its specification and that batch-to-batch variability is controlled.
The amino acid profile of collagen peptides is distinctive, with glycine, proline, and hydroxyproline together accounting for a large fraction of residues. Glycine appears at nearly every third position in the original collagen sequence, a pattern partly retained in shorter peptides. Hydroxyproline is formed by post-translational modification of proline and serves as a marker for collagen-derived material. Unlike many proteins, collagen peptides contain little or no tryptophan and low levels of cysteine.
Commercial collagen peptides are sold as free-flowing powders that dissolve readily in water, forming clear to slightly hazy solutions. They are often classified by average molecular mass, which typically falls between 2,000 and 10,000 daltons, though products with lower or higher ranges exist. Taste is generally neutral, but some fish-derived versions may have a slight odor. Applications include food and beverage fortification, cosmetic formulations, and nutraceutical capsules. The powder is often blended with other ingredients without affecting clarity.
C-5 sterol desaturase couples sterol oxidation to the oxidation of NAD(P)H and the reduction of molecular oxygen. Either NADH or NADPH can be used; in the model plant species Arabidopsis thaliana C-5 sterol desaturase catalyzes the reaction twice as fast with NADH while in S. cerevisiae the enzyme has little preference. The precise details of the reaction have been thought to vary between mammals and yeast. However, the enzymes do share a conserved cluster of histidine residues, which when mutated (in A. thaliana) dramatically reduce or eliminate enzyme activity, suggesting the involvement of a coordinated iron cation in the mechanism. Mutagenesis studies suggest that in A. thaliana threonine 114 (which is a serine in humans, mice, and yeast) may help to stabilize the enzyme-substrate complex. Rahier has proposed a reaction mechanism in which an iron-coordinated oxygen abstracts a hydrogen from the substrate leading to a radical intermediate.
Blood tests are also used to assess kidney function. These include tests that are intended to directly measure the function of the kidneys, as well as tests that assess the function of the kidneys by looking for evidence of problems associated with abnormal function. One of the measures of kidney function is the glomerular filtration rate (GFR). Other tests that can assess the function of the kidneys include assessment of urea and electrolyte levels such as potassium and phosphate, assessment of acid-base status by the measurement of bicarbonate levels from a vein, and assessment of the full blood count for anaemia.
Feoktist I. Bogoyavlenskiy (1933–1935) Vasiliy V. Evlampiev (1935–1939) Faizi F. Faizyllin (1958–1960) Boris A. Arbuzov (1941–1950) Arkadiy N. Pudovik (1950–1958) Faizi F. Faizyllin (1958–1960) Vera F. Toropova (1960–1965) Alexander I. Kostromin (1965–1968) Alexander I. Konovalov (1968–1972) Irina V. Konovalova (1972–1987) Galina A. Chmutova (1987–1992) Nikolai A. Ulakhovich (1992–2000) Vladimir I. Galkin (since 2000– until present) Department of Analytical Chemistry Department of High Molecular and Organoelement Compounds Department of Inorganic Chemistry Department of Organic Chemistry Department of Physical Chemistry Department of Chemical Education Department of Environmental Chemistry Department of Applied Chemistry Department of Stereochemistry Division for Analytical Chemistry Division for Inorganic Chemistry and Coordination chemistry Division for Organic Chemistry Division for Physical Chemistry Division for Organoelement Compounds Division for Stereochemistry Division for Applied Chemistry Division for Environmental Chemistry
MAPseq or Multiplexed Analysis of Projections by Sequencing is a RNA-Seq based method for high-throughput mapping of neuronal projections. It was developed by Anthony Zador and his team at Cold Spring Harbor Laboratory and published in Neuron, a Cell Press magazine. It has been cited over 300 times. The method works by uniquely labeling neurons in a source region by injecting a viral library encoding a diverse collection of RNA sequences ("barcodes"). The barcode mRNA is expressed at high levels and transported into the axon terminals at distal target projection regions. Following this, the cells from source and putative target regions of interest are harvested, and their RNA is extracted and sequenced. By matching the presence of the unique "barcode" in the source and target tissue, one can map the projections of neuron in a one-to-many fashion. RNA-Seq Patch-sequencing
represents the turnover rate, or the number of reactions catalyzed by an enzyme over the enzyme amount. k c a t {\displaystyle k_{cat}} over k m {\displaystyle k_{m}} is known as the specificity constant, which gives a measure of the affinity of a substrate to some particular enzyme. Also known as the efficiency of an enzyme, this relationship reveals an enzyme's preference for a particular substrate. The higher the specificity constant of an enzyme corresponds to a high preference for that substrate.
Sources: en.wikipedia.org
Databases are essential for bioinformatics research and applications. Databases exist for many different information types, including DNA and protein sequences, molecular structures, phenotypes and biodiversity. Databases can contain both empirical data (obtained directly from experiments) and predicted data (obtained from analysis of existing data). They may be specific to a particular organism, pathway or molecule of interest. Alternatively, they can incorporate data compiled from multiple other databases. Databases can have different formats, access mechanisms, and be public or private. Some of the most commonly used databases are listed below: Used in biological sequence analysis: Genbank, UniProt Used in structure analysis: Protein Data Bank (PDB) Used in finding Protein Families and Motif Finding: InterPro, Pfam Used for Next Generation Sequencing: Sequence Read Archive Used in Network Analysis: Metabolic Pathway Databases (KEGG, BioCyc), Interaction Analysis Databases, Functional Networks Used in design of synthetic genetic circuits: GenoCAD
Camurus' FluidCrystal are available as injectable depots and topical bioadhesive delivery technologies. By encapsulating the drug compound in the nanostructures, injectable depots are able to deliver therapeutic levels of drug substance over extended periods from a single injection. This leads to a decrease in traditional side effects associated with high initial drug release on injection (drug burst), poor drug stability, and complex processing requirements, making the system highly suitable for sustained parental delivery of peptides, proteins, and small molecule drug compounds. The topical delivery system creates a bio-adhesive film that provides local and continual release of drug compounds. The delivery system is suited for delivery of peptide, protein, and small molecule drug compounds and can be applied to dermal, buccal, ophthalmic, nasal, vaginal, and other topical surfaces.
Antimicrobial peptides are produced by species across the tree of life, including: bacteria (e.g. bacteriocin, and many others) fungi (e.g. peptaibols, plectasin, and many others) cnidaria (e.g. hydramacin, aurelin) many from insects and arthropods (e.g. cecropin, attacin, melittin, mastoparan, drosomycin, thioester-containing protein 1) amphibia, frogs (magainin, dermaseptin, aurein, and others) birds (e.g. avian defensins) and mammals (e.g. cathelicidins, alpha- and beta-defensins, regIII peptides) Research has increased in recent years to develop artificially-engineered mimics of antimicrobial peptides such as SNAPPs, in part due to the prohibitive cost of producing naturally-derived AMPs. An example of this is the facially cationic peptide C18G, which was designed from the C-terminal domain of human platelet factor IV. Currently, the most widely used antimicrobial peptide is nisin; being the only FDA approved antimicrobial peptide, it is commonly used as an artificial preservative.
C11orf91 has a predicted Protein kinase C (PKC) phosphorylation site, Casein kinase 2 (CK2) phosphorylation site, amidation site, and two predicted serine phosphorylation sites, see Conceptual Translation for post-translational modification site locations. There are no paralogs of the human C11orf91 protein. The human C11orf91 protein has several orthologs found across eight categories of jawed vertebrates including: aves, testudines, alligators, reptiles, mammals, amphibians, lungfishes, and cartilaginous fishes.
Beano is an enzyme-based dietary supplement that is used to reduce gas in the digestive tract, thereby improving digestion and reducing bloating, discomfort, and flatulence caused by gas. It contains the enzyme alpha-galactosidase (α-GAL). It was introduced as a liquid, but that has been discontinued and it is now available only as tablets and strawberry-flavored "Meltaways". Beano is marketed and distributed by Prestige Consumer Healthcare, Inc.
Sources: en.wikipedia.org
TTP's (ZFP36's) expression is rapidly induced by insulin. Immunoprecipitation experiments have shown that TTP co-precipitates with an exosome, suggesting that it helps recruit exosomes to the mRNA containing AREs. TTP appears to promote the processive deadenylation activity of CCR4–NOT on mRNAs containing AREs, with phosphorylation-dependent interactions with cytoplasmic poly(A)-binding protein (PABPC1) potentially enhancing deadenylation and promoting regulated mRNA decay. TTP can also repress mRNA translation after binding to AREs by using 4EHP-GYF2 as a cofactor. Alternatively, HuR proteins have a stabilizing effect—their binding to AREs increases the half-life of mRNAs. Similar to other RNA-binding proteins, this class of proteins contain three RRMs, two of which are specific to ARE elements. A likely mechanism for HuR action relies on the idea that these proteins compete with other proteins that normally have a destabilizing effect on mRNAs. HuRs are involved in genotoxic response—they accumulate in the cytoplasm in response to UV exposure and stabilize mRNAs that encode proteins involved in DNA repair.
In 1974, GM offered driver and passenger airbags as optional equipment on large Cadillacs, Buicks, and Oldsmobiles. In 1976, the crash test dummy Hybrid III was introduced to assess the impacts of car collisions. It represented the 50th percentile male standing at approximately 5' 9" tall and weighing 78 kg (171 lbs). In 1979, NHTSA began crash-testing popular cars and publishing the results, to inform consumers and encourage manufacturers to improve the safety of their vehicles. Initially, the US NCAP (New Car Assessment Program) crash tests examined compliance with the occupant-protection provisions of FMVSS 208. Over the subsequent years, this NHTSA program was gradually expanded in scope.
Commercial availability varies by country. Approved systems in various countries, described further below, include MiniMed 670G or 780G, Tandem's Control-IQ, Omnipod 5, CamAPS FX, and Diabeloop DBLG1. In September 2016, the FDA approved the Medtronic MiniMed 670G, which was the first approved hybrid closed loop system. The device automatically adjusts a patient's basal insulin delivery. It is made up of a continuous glucose monitor, an insulin pump, and a glucose meter for calibration. It automatically functions to modify the level of insulin delivery based on the detection of blood glucose levels by continuous monitor. It does this by sending the blood glucose data through an algorithm that analyzes and makes the subsequent adjustments. The system has two modes. Manual mode lets the user choose the rate at which basal insulin is delivered. Auto mode regulates basal insulin levels from the CGM readings every five minutes.
The predecessor of modern countercurrent chromatography theory and practice was countercurrent distribution (CCD). The theory of CCD was described in the 1930s by Randall and Longtin. Archer Martin and Richard Laurence Millington Synge developed the methodology further during the 1940s. Finally, Lyman C. Craig introduced the Craig countercurrent distribution apparatus in 1944 which made CCD practical for laboratory work. CCD was used to separate a wide variety of useful compounds for several decades.
Sources: en.wikipedia.org
They are produced by hydrolyzing collagen from animal or fish sources using enzymes or chemicals. The process breaks the protein into shorter chains. Filtration, concentration, and drying follow to create a powder.
Size exclusion chromatography is commonly used to estimate molecular weight distribution. Mass spectrometry can provide detailed information on individual peptide sequences. Both methods complement each other for quality control.
Store in a cool, dry place away from moisture and light, in a sealed container. Refrigeration may extend shelf life for long-term storage. Prepared solutions should be used promptly or stabilized as needed.
They are typically produced from animal connective tissues, such as bovine hide, porcine skin, or fish scales. The raw material is hydrolyzed to break down native collagen into smaller peptide chains.